Topic: How To Invest

What is Pat’s commentary for the week of October 1, 2024

Article Excerpt

ResMed’s sales and profits got a boost during the pandemic with a sharp rise in demand for its ventilators and other respiration devices. Even as the pandemic eased, the gains continued as the company introduced more products and expanded its software offerings. Today, ResMed’s outlook remains attractive, and not just for its CPAP machines. Those devices successfully treat sleep apnea, which gets far less media attention than other health issues such as high blood pressure, obesity, diabetes, depression, stroke and heart problems. Still, more and more public and private health insurers have begun to recognize, publicize and pay for sleep apnea treatment. That’s because untreated, it can lead to several complications requiring much more costly treatment. People who are only vaguely familiar with sleep apnea may think of it as a disease of the elderly. But it can strike anyone, children included. We think this discrepancy in awareness creates a great long-term opportunity for ResMed. In fact, the stock is up more…